Factors affecting the choice of budesonide in the therapy of croup, asthma and chronic obstructive pulmonary disease.

Olszanecka-Glinianowicz, Magdalena; Chudek, Jerzy; Urcus, Anna; Almgren-Rachtan, Agnieszka

Olszanecka-Glinianowicz, Magdalena; Chudek, Jerzy; Urcus, Anna; Almgren-Rachtan, Agnieszka.

Afiliação

Olszanecka-Glinianowicz M; Health Promotion and Obesity Management Unit, Department of Pathophysiology, Medical Faculty in Katowice, Medical University of Silesia, Katowice, Poland.
Chudek J; Department of Internal Medicine and Oncological Chemotherapy, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland.
Urcus A; Adamed Pharma, Poland.
Almgren-Rachtan A; Pharmacovigilance Department, Europharma, Katowice, Poland.

Postepy Dermatol Alergol ; 39(5): 893-901, 2022 Oct.

Article em En | MEDLINE | ID: mdl-36457671

Palavras-chave

asthma; budesonide; chronic obstructive pulmonary disease; croup; efficacy; safety; therapeutic preferences

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: Postepy Dermatol Alergol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Polônia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google